P. 1
Atazanavir - Patent Landscape Report

Atazanavir - Patent Landscape Report

|Views: 283|Likes:
Atazanavir is an antiretroviral drug from the protease inhibitor class used to treat HIV infection and AIDS. It is included in the WHO Model List of Essential Medicines (EML). This report examines the evolution of the patent environment protecting Atazanavir from the first filing of this compound in July 1995 by CIBA-GEIGY to the present filings. It also provides insight into best practice for probing the patent literature in the pharmaceutical area.
Atazanavir is an antiretroviral drug from the protease inhibitor class used to treat HIV infection and AIDS. It is included in the WHO Model List of Essential Medicines (EML). This report examines the evolution of the patent environment protecting Atazanavir from the first filing of this compound in July 1995 by CIBA-GEIGY to the present filings. It also provides insight into best practice for probing the patent literature in the pharmaceutical area.

More info:

Categories:Types, Business/Law
Copyright:Attribution Non-commercial

Availability:

Read on Scribd mobile: iPhone, iPad and Android.
download as PDF, TXT or read online from Scribd
See more
See less

03/15/2013

pdf

text

original

Clinical names are far more usable than chemical names from the searcher’s point of view.
They are distinctive and crucially, they are the same in any language. These names are the
best resource for compiling a collection of patents that could be called “Clinical Collection”
because they relate to the drug after it has begun to be tested clinically.

You're Reading a Free Preview

Download
scribd